TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31158739

Group type: EXPERIMENTAL
Intervention: Olive leaf tea (OLT)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Low-concentration olive leaf tea (LOLT)
Number of subjects: 57
Study: 29101597

Group type: EXPERIMENTAL
Intervention: 4.3 g/day n-3 PUFA supplements
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: COMPARATOR
Intervention: 4.3 g/day n-3 PUFA supplements vs Placebo
Number of subjects: 44
Study: 26756752

Group type: EXPERIMENTAL
Intervention: Oral and parenteral prophylaxis (1 g cefmetazole before and every 3 h during surgery plus 1 g oral kanamycin and 750 mg metronidazole twice on the day before surgery)
Number of subjects: 579

Group type: COMPARATOR
Intervention: Parenteral prophylaxis alone (1 g cefmetazole before and every 3 h during surgery)
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Oral and parenteral prophylaxis
Number of subjects: 579

Group type: COMPARATOR
Intervention: Parenteral prophylaxis alone
Number of subjects: 579
Study: 24670025

Group type: EXPERIMENTAL
Intervention: Topical tetracycline (5 mL)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Isotonic saline (5 mL)
Number of subjects: 96
Study: 23000202

Group type: EXPERIMENTAL
Intervention: Docetaxel-prednisone
Number of subjects: 221
Study: 20172126

Group type: EXPERIMENTAL
Intervention: Preoperative statin therapy
Number of subjects: 10061

Group type: COMPARATOR
Intervention: No statin therapy
Number of subjects: 10061
Study: 18981485

Group type: EXPERIMENTAL
Intervention: MK‐677, 25 mg, once daily
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 15979192

Group type: EXPERIMENTAL
Intervention: Sertraline, 50 mg/24 h
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ultrasonography and physical therapy (15 sessions of 1 W/cm2 on cervical trigger points)
Number of subjects: 70
Study: 12439086

Group type: EXPERIMENTAL
Intervention: G(1): 8 x 60% T(max) at P(max), 1:2 work:recovery ratio
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: G(2): 8 x 60% T(max) at P(max), recovery at 65% HR(max)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: G(3): 12 x 30 s at 175% PPO, 4.5-min recovery
Number of subjects: 38

Group type: COMPARATOR
Intervention: G(CON): Control group
Number of subjects: 38
Study: 12161053

Group type: EXPERIMENTAL
Intervention: 50 mg/day losartan
Number of subjects: 33

Group type: COMPARATOR
Intervention: 10 mg/day fosinopril
Number of subjects: 33
Study: 9802743

Group type: EXPERIMENTAL
Intervention: 900 mg vitamin E for 6 months
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 21
Study: 8567766

Group type: EXPERIMENTAL
Intervention: Gonadotrophin-releasing hormone agonist (GnRHa) 0.1 mg s.c.
Number of subjects: 210

Group type: COMPARATOR
Intervention: Human chorionic gonadotrophin (HCG) 10,000 IU i.m.
Number of subjects: 210
Study: 2763278

Group type: EXPERIMENTAL
Intervention: Chemical pleurodesis (tetracycline and 30% glucose)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pleural drainage alone
Number of subjects: 20
Study: 668773

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 12.5 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 75 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (various doses)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31035960

Group type: EXPERIMENTAL
Intervention: Metformin 500 mg twice daily
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 19
Study: 28389484

Group type: EXPERIMENTAL
Intervention: Personal frequency-modulated systems (FMs) used daily over 10 weeks by 4 patients (intervention care subjects)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Standard care received by 5 patients (standard care subjects)
Number of subjects: 9
Study: 25842726

Group type: EXPERIMENTAL
Intervention: Short heating time length group (15 min of moxibustion therapy)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Moderate heating time length group (30 min of moxibustion therapy)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Long heating time length group (60 min of moxibustion therapy)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional acupuncture group (control)
Number of subjects: 40
Study: 23373762

Group type: EXPERIMENTAL
Intervention: Individual dietary counselling
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 89
Study: 21330587

Group type: EXPERIMENTAL
Intervention: Peer-driven intervention (6 hours of structured sessions and the opportunity to educate 3 peers)
Number of subjects: 342

Group type: COMPARATOR
Intervention: Control intervention (time-matched)
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Peer-driven intervention (experience of recruiting and educating peers)
Number of subjects: 342
Study: 21994102

Group type: EXPERIMENTAL
Intervention: Ocular gaze deviation (OGD) measurement in patients with acute ischemic stroke (Group 1)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Ocular gaze deviation (OGD) measurement in ambulatory outpatients (Group 2)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Conjugate and disconjugate gaze evaluation in both groups
Number of subjects: 116
Study: 16907670

Group type: EXPERIMENTAL
Intervention: Undercorrected group (blurred by +0.50 D)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Fully corrected group
Number of subjects: 48
Study: 15006188

Group type: EXPERIMENTAL
Intervention: APV/RTV 600/100 mg twice daily
Number of subjects: 35
Study: 11709566

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (four cycles of fluorouracil, epirubicin, and cyclophosphamide)
Number of subjects: 698

Group type: COMPARATOR
Intervention: Postoperative chemotherapy (same regimen administered postoperatively)
Number of subjects: 698

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy
Number of subjects: 698

Group type: COMPARATOR
Intervention: Postoperative chemotherapy
Number of subjects: 698
Study: 9304332

Group type: EXPERIMENTAL
Intervention: Intranasal immunization with inactivated influenza vaccine (IIV)
Number of subjects: 856

Group type: COMPARATOR
Intervention: Control group (no immunization)
Number of subjects: 856
Study: 8105790

Group type: EXPERIMENTAL
Intervention: Nalmefene augmentation
Number of subjects: 11
Study: 3301925

Group type: EXPERIMENTAL
Intervention: Intralesional fluorouracil (1 ml of 50 mg/ml)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control lesions (no treatment)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Intralesional fluorouracil
Number of subjects: 11
Study: 30870576

Group type: EXPERIMENTAL
Intervention: Zoledronate (4 mg doses, two annual doses)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 30223447

Group type: EXPERIMENTAL
Intervention: Vitamin D₃ supplementation (5000 IU/day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 25
Study: 26678102

Group type: EXPERIMENTAL
Intervention: Resorbable plates/screws (group A)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Titanium plates/screws (group B)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 27
Study: 24768894

Group type: EXPERIMENTAL
Intervention: Stress task (Trier Social Stress Test)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: High inhibitory control
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: A-typical hunger stress response
Number of subjects: 54
Study: 23072964

Group type: EXPERIMENTAL
Intervention: CI only
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Bimodal conditions
Number of subjects: 9

Group type: COMPARATOR
Intervention: LFT-on
Number of subjects: 9

Group type: COMPARATOR
Intervention: LFT-off
Number of subjects: 9
Study: 21510461

Group type: EXPERIMENTAL
Intervention: Acarbose (50 mg) + Metformin (500 mg) bid/tid (n=115)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Metformin (500 mg) bid/tid (n=114)
Number of subjects: 229
Study: 18637534

Group type: EXPERIMENTAL
Intervention: Zinc therapy
Number of subjects: 0
Study: 15956865

Group type: EXPERIMENTAL
Intervention: Paper-based screening
Number of subjects: 473

Group type: COMPARATOR
Intervention: Interview-based screening
Number of subjects: 473
Study: 12616661

Group type: EXPERIMENTAL
Intervention: Lidocaine patch 5% (Lidoderm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extended application of lidocaine patch 5%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous application of up to four patches per day
Number of subjects: 0
Study: 10623695

Group type: EXPERIMENTAL
Intervention: Pamidronate 90 mg administered intravenously every month
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8646314

Group type: EXPERIMENTAL
Intervention: Computer-assisted instruction unit
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no computer-assisted instruction)
Number of subjects: 0
Study: 1355981

Group type: EXPERIMENTAL
Intervention: Alpha-adrenoceptor blockade with phentolamine
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Combined alpha-adrenoceptor, beta-adrenoceptor (propranolol) and parasympathetic (atropine) blockade
Number of subjects: 7
Study: 6386481

Group type: EXPERIMENTAL
Intervention: miniheparin (2 X 2500 IU daily)‐dihydroergotamine
Number of subjects: 50

Group type: COMPARATOR
Intervention: conventional low‐dose heparin
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50
Study: 3091407

Group type: EXPERIMENTAL
Intervention: Monash protocol (RWH patients)
Number of subjects: 60

Group type: COMPARATOR
Intervention: RWH control (RWH patients)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: RWH protocol (Monash patients)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Monash control (Monash patients)
Number of subjects: 60
Study: 29898793

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy for Insomnia (CBT-I)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relaxation training (active control)
Number of subjects: 0
Study: 28386791

Group type: EXPERIMENTAL
Intervention: Genetic risk score (GRS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional risk score (CRS)
Number of subjects: 0
Study: 26354539

Group type: EXPERIMENTAL
Intervention: Beef ingestion (30 g protein)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Milk ingestion (30 g protein)
Number of subjects: 12
Study: 23301686

Group type: EXPERIMENTAL
Intervention: Oxycodone PR 10 mg + Naloxone PR 5 mg
Number of subjects: 85

Group type: COMPARATOR
Intervention: Oxycodone PR 10 mg
Number of subjects: 85
Study: 21085590

Group type: EXPERIMENTAL
Intervention: Sensitizers
Number of subjects: 36

Group type: COMPARATOR
Intervention: Fluctuating subjects
Number of subjects: 36

Group type: COMPARATOR
Intervention: Repressors
Number of subjects: 36
Study: 17926079

Group type: EXPERIMENTAL
Intervention: ALA and Photofrin fluorescence-guided resection and repetitive photodynamic therapy (PDT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: ALA and Photofrin fluorescence-guided resection and repetitive PDT
Number of subjects: 27
Study: 17132752

Group type: EXPERIMENTAL
Intervention: Lanreotide treatment
Number of subjects: 52

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 52
Study: 12477613

Group type: EXPERIMENTAL
Intervention: Computer-tailored three-step decision-aid
Number of subjects: 289
Study: 9819045

Group type: EXPERIMENTAL
Intervention: Continuous infusion of factor VIII (FVIII) concentrates
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Continuous infusion of factor IX (FIX) concentrates
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control non-haemophilic patients with heparin prophylaxis
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Bolus dose of 50 U/kg of a very high purity clotting factor concentrate
Number of subjects: 13
Study: 7659762

Group type: EXPERIMENTAL
Intervention: Amphetamine (oral administration before learning)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amphetamine (intramuscular injection after learning)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amphetamine (during the 1st hour after learning)
Number of subjects: 0

Group type: COMPARATOR
Intervention: General arousal or attentional processes
Number of subjects: 0
Study: 2757893

Group type: EXPERIMENTAL
Intervention: 155 mg oral tablet of hydroxychloroquine
Number of subjects: 5

Group type: COMPARATOR
Intervention: Intravenous infusion of 155 mg racemic hydroxychloroquine
Number of subjects: 5
Study: 334473

Group type: EXPERIMENTAL
Intervention: 100 mg flurbiprofen 3-times daily for 3 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Joint scanning of 99mTc uptake
Number of subjects: 14
Study: 30647912

Group type: EXPERIMENTAL
Intervention: DSF combined with nutritional copper supplement (DSF-Cu) as an adjuvant to alkylating chemotherapy
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group without DSF-Cu
Number of subjects: 142
Study: 27209501

Group type: EXPERIMENTAL
Intervention: Prone whole-breast irradiation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Supine whole-breast irradiation
Number of subjects: 100
Study: 24399871

Group type: COMPARATOR
Intervention: Whole Body Vibration (WBV) training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Circuit resistance training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower body strength
Number of subjects: 0
Study: 22173608

Group type: EXPERIMENTAL
Intervention: PVP combined with chemotherapy
Number of subjects: 76

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 76
Study: 20512501

Group type: EXPERIMENTAL
Intervention: Cycling (20 min sub-maximal cycling in an upright position with relaxed shoulders)
Number of subjects: 25
Study: 18641114

Group type: EXPERIMENTAL
Intervention: Continuous aspiration of subglottic secretions (CASS)
Number of subjects: 714
Study: 15730579

Group type: EXPERIMENTAL
Intervention: Simple decompression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anterior subcutaneous transposition
Number of subjects: 0
Study: 12939125

Group type: EXPERIMENTAL
Intervention: Standard intervention to increase consumption of fruit and vegetables to at least five portions per day (received by intervention participants).
Number of subjects: 729

Group type: COMPARATOR
Intervention: Control group (received the same intervention after 6 months).
Number of subjects: 729
Study: 10363570

Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 7862546

Group type: EXPERIMENTAL
Intervention: Jaw relaxation
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Combination of relaxation and music
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Jaw relaxation and music (combined)
Number of subjects: 84
Study: 2127044

Group type: EXPERIMENTAL
Intervention: MCT/LCT mixture (50% MCT and 50% LCT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: LCT (long-chain triglycerides)
Number of subjects: 24
Study: 7420563

Group type: EXPERIMENTAL
Intervention: 3-day treatment with penicillin-G
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10-day treatment with trimethoprim-sulfamethoxazole
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: trimethoprim-sulfamethoxazole
Number of subjects: 60

Group type: COMPARATOR
Intervention: 10-day treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3-day regimen
Number of subjects: 60
Study: 31596655

Group type: EXPERIMENTAL
Intervention: Test‐snack
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control‐snack
Number of subjects: 17

Group type: COMPARATOR
Intervention: Bread
Number of subjects: 17
Study: 31539171

Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.05% vaginal cleansing
Number of subjects: 320

Group type: COMPARATOR
Intervention: No cleansing (control)
Number of subjects: 320
Study: 28969509

Group type: EXPERIMENTAL
Intervention: Consumption of orange-fleshed sweet potato (OFSP)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Household production of OFSP
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Purchasing of OFSP
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Knowledge on health benefits of OFSP
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Presence of children aged less than 5 years
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Production of OFSP
Number of subjects: 295
Study: 27377450

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Group Therapy for Recovery of Self-Esteem (CBGTRS), 12 group sessions
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study: 24329187

Group type: EXPERIMENTAL
Intervention: Risperidone 2.5 mg
Number of subjects: 25
Study: 22267373

Group type: EXPERIMENTAL
Intervention: Letrozole 5 mg daily for 5 days
Number of subjects: 106

Group type: COMPARATOR
Intervention: Clomiphene citrate 100 mg daily for 5 days
Number of subjects: 106
Study: 20479349

Group type: EXPERIMENTAL
Intervention: Two 90‐minute team skills training sessions
Number of subjects: 0
Study: 17564197

Group type: EXPERIMENTAL
Intervention: Auditory information agreeing with vision (group 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Auditory information agreeing with proprioception (group 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No auditory information (group 3)
Number of subjects: 0
Study: 16109821

Group type: EXPERIMENTAL
Intervention: Evidence based prevention programme including educational activities and recommendations
Number of subjects: 644

Group type: COMPARATOR
Intervention: Comparison departments (control)
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Intervention activities
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Discussion of skin problems
Number of subjects: 644
Study: 12685522

Group type: EXPERIMENTAL
Intervention: Ritalin LA, Metadate CD, Concerta, Adderall XR (new long-acting formulations of MPH and AMP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bolus delivery (BD) and controlled delivery (CD) processes used in drug delivery systems
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laboratory School Protocol (LSP)
Number of subjects: 0
Study: 10987232

Group type: EXPERIMENTAL
Intervention: Surgery and radiotherapy (lumpectomy and axillary dissection followed by external beam radiotherapy)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Extent of axillary dissection (number of nodes retrieved)
Number of subjects: 266
Study: 8690115

Group type: EXPERIMENTAL
Intervention: Bromocriptine-rebound method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long protocol
Number of subjects: 0
Study: 1866002

Group type: EXPERIMENTAL
Intervention: 75 mg dipyridamole and 330 mg acetylsalicylic acid tid
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2500
Study: 7102534

Group type: EXPERIMENTAL
Intervention: Pindolol, 10 mg twice a day (n = 7)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Propranolol, median dose 80 mg three times a day (n = 9)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Metoprolol, 150 mg twice a day (n = 8)
Number of subjects: 24
Study: 31943195

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lasmiditan (phase 3)
Number of subjects: 0
Study: 31282306

Group type: EXPERIMENTAL
Intervention: Wearable resistance (WR) of 2% body mass
Number of subjects: 15
Study: 27987040

Group type: EXPERIMENTAL
Intervention: Atorvastatin 60 mg (AT60, n=16)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg (AT20, n=14)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overall treatment with atorvastatin (both doses)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Plaques with ACS
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Plaques with stable angina
Number of subjects: 30
Study: 27009449

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (0.625 mg/0.025 ml)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Conventional indirect laser therapy
Number of subjects: 79
Study: 24487616

Group type: EXPERIMENTAL
Intervention: Exercise (16.5 kcal/kg/week of aerobic exercise, three times per week)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (treatment as usual, no exercise)
Number of subjects: 26
Study: 23046818

Group type: EXPERIMENTAL
Intervention: COACH programme delivered by primary care physicians assisted by nurse educators (PCP-NE)
Number of subjects: 297

Group type: COMPARATOR
Intervention: COACH programme delivered by primary care physicians (PCP) alone
Number of subjects: 297
Study: 20181239

Group type: EXPERIMENTAL
Intervention: Cognitive oriented consultation offered two weeks after injury (intervention group).
Number of subjects: 326

Group type: COMPARATOR
Intervention: No intervention (control group).
Number of subjects: 326
Study: 17321110

Group type: EXPERIMENTAL
Intervention: Folic acid (10 mg, three times weekly for 6 months)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 16263618

Group type: EXPERIMENTAL
Intervention: Closed treatment
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 127
Study: 11904101

Group type: EXPERIMENTAL
Intervention: Chronic lymphatic filariasis patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls (non-affected individuals)
Number of subjects: 0
Study: 10451081

Group type: EXPERIMENTAL
Intervention: Abdominal muscle strengthening exercise and back education
Number of subjects: 402

Group type: COMPARATOR
Intervention: Back education only
Number of subjects: 402
Study: 8287870

Group type: EXPERIMENTAL
Intervention: Trimetazidine 6 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3323261

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 151

Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 151
Study: 31242079

Group type: EXPERIMENTAL
Intervention: HDC/IL-2
Number of subjects: 0